Description:

Maball contains Rituximab as composition. Rituximab is a genetically engineered chimeric human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences. Maball belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Maball 100Mg Injection and Maball 500Mg Injection.

Write to Us

Share your experience with our medical product. Write a review!

Blog

25 Mar 2026

Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief

Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more

Read More

14 Mar 2026

How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices

A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes

Read More

05 Feb 2026

Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally

Diet plays a crucial role in the development and management of type 2 diabetes.

Read More

20 Jan 2026

PCOS Symptoms and Management: Signs Most Women Overlook

Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.

Read More